Cellectis Sylvie

Cellectis appoints Dr Sylvie Delassus Senior Vice President Communications

pharmafile | October 20, 2009 | Appointment | Research and Development |  appointment, cellectis, research and development 

French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive committee.

Cellectis said the appointed reflected its commitment to developing an ambitious, strategically coherent corporate communications programme.

Sylvie Delassus spent 11 years as a researcher in virology and immunology at the Institut Pasteur in Paris and the Institute of Cancer Research in London.

Advertisement

She served as public relations director at the Institut Pasteur from 2000 to 2004 and then spent two years as head of communications for the R&D subsidiary of Aventis.

Following that Delassus worked at the French Agency for Environmental and Occupational Health and Safety (Afsset) with a special focus on developing the scientific aspects of the agency’s communication and increasing its contribution to public debate.

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …

The Gateway to Local Adoption Series

Latest content